119 related articles for article (PubMed ID: 1288361)
1. The involvement of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease.
Potter H; Nelson RB; Das S; Siman R; Kayyali US; Dressler D
Ann N Y Acad Sci; 1992 Dec; 674():161-73. PubMed ID: 1288361
[No Abstract] [Full Text] [Related]
2. The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease.
Potter H
Prog Brain Res; 1992; 94():447-58. PubMed ID: 1287729
[No Abstract] [Full Text] [Related]
3. Proteases and Protease Inhibitors in Alzheimer's Disease Pathogenesis. Proceedings of a conference. Bethesda, Maryland, December 16-18, 1991.
Ann N Y Acad Sci; 1992 Dec; 674():1-259. PubMed ID: 1363188
[No Abstract] [Full Text] [Related]
4. A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity.
Wolfe MS; Citron M; Diehl TS; Xia W; Donkor IO; Selkoe DJ
J Med Chem; 1998 Jan; 41(1):6-9. PubMed ID: 9438016
[No Abstract] [Full Text] [Related]
5. Identification of the multicatalytic enzyme as a possible gamma-secretase for the amyloid precursor protein.
Mundy DI
Biochem Biophys Res Commun; 1994 Oct; 204(1):333-41. PubMed ID: 7945379
[TBL] [Abstract][Full Text] [Related]
6. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
Pollack SJ; Lewis H
Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
[TBL] [Abstract][Full Text] [Related]
7. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D.
Evin G; Cappai R; Li QX; Culvenor JG; Small DH; Beyreuther K; Masters CL
Biochemistry; 1995 Oct; 34(43):14185-92. PubMed ID: 7578016
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid P and related molecules associated with the acute-phase response in Alzheimer's disease.
Kalaria RN
Res Immunol; 1992; 143(6):637-41. PubMed ID: 1280849
[No Abstract] [Full Text] [Related]
9. Identification of inhibitors of the transmembrane protease FlaK of Methanococcus maripaludis.
Coburger I; Schaub Y; Roeser D; Hardes K; Maeder P; Klee N; Steinmetzer T; Imhof D; Diederich WE; Than ME
Microbiologyopen; 2016 Aug; 5(4):637-46. PubMed ID: 27038342
[TBL] [Abstract][Full Text] [Related]
10. A synthetic substrate assay for the gamma-secretase of the beta-A4 amyloid of Alzheimer's disease.
Evin G; Beyreuther K; Masters CL
J Pept Sci; 1995; 1(2):132-9. PubMed ID: 9222990
[TBL] [Abstract][Full Text] [Related]
11. Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease.
Evin G; Sharples RA; Weidemann A; Reinhard FB; Carbone V; Culvenor JG; Holsinger RM; Sernee MF; Beyreuther K; Masters CL
Biochemistry; 2001 Jul; 40(28):8359-68. PubMed ID: 11444983
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin D displays in vitro beta-secretase-like specificity.
Chevallier N; Vizzavona J; Marambaud P; Baur CP; Spillantini M; Fulcrand P; Martinez J; Goedert M; Vincent JP; Checler F
Brain Res; 1997 Mar; 750(1-2):11-9. PubMed ID: 9098524
[TBL] [Abstract][Full Text] [Related]
13. Proteases during purification.
Kresze GB
Bioprocess Technol; 1991; 12():85-120. PubMed ID: 1367503
[No Abstract] [Full Text] [Related]
14. Aspartic proteases involved in Alzheimer's disease.
Schmidt B
Chembiochem; 2003 May; 4(5):366-78. PubMed ID: 12740808
[TBL] [Abstract][Full Text] [Related]
15. Protease inhibition causes some manifestations of aging and Alzheimer's disease in rodent and primate brain.
Ivy GO
Ann N Y Acad Sci; 1992 Dec; 674():89-102. PubMed ID: 1337691
[No Abstract] [Full Text] [Related]
16. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway.
Hook VY; Reisine TD
J Neurosci Res; 2003 Nov; 74(3):393-405. PubMed ID: 14598316
[TBL] [Abstract][Full Text] [Related]
17. Functional determinants of the Epstein-Barr virus protease.
Buisson M; Valette E; Hernandez JF; Baudin F; Ebel C; Morand P; Seigneurin JM; Arlaud GJ; Ruigrok RW
J Mol Biol; 2001 Aug; 311(1):217-28. PubMed ID: 11469870
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule inhibitors and probes for ubiquitin- and ubiquitin-like-specific proteases.
Borodovsky A; Ovaa H; Meester WJ; Venanzi ES; Bogyo MS; Hekking BG; Ploegh HL; Kessler BM; Overkleeft HS
Chembiochem; 2005 Feb; 6(2):287-91. PubMed ID: 15651044
[No Abstract] [Full Text] [Related]
19. Computational approaches to the prediction of blood-brain barrier permeability: A comparative analysis of central nervous system drugs versus secretase inhibitors for Alzheimer's disease.
Rishton GM; LaBonte K; Williams AJ; Kassam K; Kolovanov E
Curr Opin Drug Discov Devel; 2006 May; 9(3):303-13. PubMed ID: 16729726
[TBL] [Abstract][Full Text] [Related]
20. Proteases--structures, mechanism and inhibitors.
Powers JC; Odake S; Oleksyszyn J; Hori H; Ueda T; Boduszek B; Kam C
Agents Actions Suppl; 1993; 42():3-18. PubMed ID: 8356929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
